ArticleJournal of clinical medicine2026

Comparative Safety Profiles of Sacituzumab Govitecan and Datopotamab Deruxtecan: A Real-World Pharmacovigilance Study.

Ziya Kalkan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.